We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 353 start-ups with an aggregate funding of $11.9b. The average funding per company in this subset is $172.9m.
Last update to the database: Feb 18, 2025. See changelog.
5
Funding Rounds
$5.1m
Money raised
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
5
Funding Rounds
$390.0m
Money raised
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
10
Funding Rounds
$930.0m
Money raised
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
1
Funding Rounds
$25.3m
Money raised
Leo Cancer Care is a company developing upright radiotherapy solutions.
4
Funding Rounds
$1.8b
Money raised
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
8
Funding Rounds
$71.3m
Money raised
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
6
Funding Rounds
$399.8m
Money raised
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
3
Funding Rounds
$313.0m
Money raised
Flatiron Health is a startup that organizes real-time oncology data to help cancer patients and doctors.
10
Funding Rounds
$410.0m
Money raised
Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
5
Funding Rounds
$68.7m
Money raised
AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that developed strains of Ammonia Oxidizing Bacteria (AOB) to administer live in treatments that address inflammatory conditions.
5
Funding Rounds
$48.1m
Money raised
Spire is a company developing tags that provide health tracking including respiration, sleep, stress, activity, and pulse rate.
6
Funding Rounds
$15.8m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
3
Funding Rounds
$32.0m
Money raised
miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
6
Funding Rounds
$86.6m
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
4
Funding Rounds
$140.0m
Money raised
Mission Bio is a South San Francisco based company that develops single-cell DNA analysis and precision genomics.
3
Funding Rounds
$31.2m
Money raised
Deep Lens is an Artificial Intelligence company matching patients with clinical trials.
2
Funding Rounds
$164.5m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
8
Funding Rounds
$967.6m
Money raised
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
2
Funding Rounds
$67.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
5
Funding Rounds
$155.6m
Money raised
Athelas is a company developing blood testing device that utilizes deep learning and computer vision.
2
Funding Rounds
$18.1m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
4
Funding Rounds
$743.2m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
2
Funding Rounds
$13.8m
Money raised
A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function.
7
Funding Rounds
$249.0m
Money raised
Eko Health is a digital health and AI technology company developing tools for heart and lung disease detection.
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
7
Funding Rounds
$65.4m
Money raised
Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.
4
Funding Rounds
$7.1m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
8
Funding Rounds
$160.3m
Money raised
Breathalyzer device maker for the early detection of cancer.
1
Funding Rounds
$77.0m
Money raised
MiRXES is a Singapore-based biotechnology company specializing in microRNA-based diagnostics founded in 2014.
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
3
Funding Rounds
$67.0m
Money raised
Faeth Therapeutics is a start-up that focuses on using nutrition and metabolism to fight cancer.
5
Funding Rounds
$14.5m
Money raised
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
2
Funding Rounds
$11.5m
Money raised
An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.
1
Funding Rounds
$1.0m
Money raised
Sanguine is a company that has the mission to accelerate medical research by eliminating the barriers to patient participation.
4
Funding Rounds
$96.5m
Money raised
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy.
3
Funding Rounds
$60.0m
Money raised
A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.
1
Funding Rounds
$150.0k
Money raised
CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.
5
Funding Rounds
$19.7m
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
2
Funding Rounds
$58.4m
Money raised
ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.
2
Funding Rounds
$386.0m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
9
Funding Rounds
$807.7m
Money raised
HeartFlow is a company developing non-invasive cardiovascular disease detection technology.
1
Funding Rounds
Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.
1
Funding Rounds
$5.5m
Money raised
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
2
Funding Rounds
$100.0m
Money raised
Snipr Biome is a synthetic biology company using CRISPR to make products for the microbiome.
9
Funding Rounds
$56.6m
Money raised
A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.
9
Funding Rounds
$4.3m
Money raised
A computational immunology and vaccine development company based in Providence, Rhode Island. It was founded in 1998.
5
Funding Rounds
$26.0m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
2
Funding Rounds
$195.5m
Money raised
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
1
Funding Rounds
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
1
Funding Rounds
$2.0m
Money raised
A&G Pharmaceutical is a Columbia, Maryland-based theranostics company developing personalized cancer therapeutics through cancer-specific monoclonal antibodies.
1
Funding Rounds
$16.0m
Money raised
A pharmaceutical company that develops topical products to treat rare diseases
3
Funding Rounds
$105.0m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
2
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
3
Funding Rounds
$32.5m
Money raised
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
7
Funding Rounds
$195.5m
Money raised
Epic Sciences is a San Diego-based company founded in 2008 by Jorge Nieva, David Nelson and Peter Kuhn.
1
Funding Rounds
Promega is a Madison, Wisconsin-based biotechnology company developing products for research, drug discovery, forensics, paternity testing, and diagnostic applications.
1
Funding Rounds
$7.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$42.2m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
4
Funding Rounds
$270.0m
Money raised
Small Molecules
6
Funding Rounds
$117.7m
Money raised
AliveCor is a San Francisco-based company developing AI-based ECG technologies.
1
Funding Rounds
$22.0m
Money raised
Biomedical Artificial Intelligence company developing products for early cancer detection in the breast.
3
Funding Rounds
$26.9m
Money raised
Moving Analytics is developing a virtual care management software for cardiac rehab.
3
Funding Rounds
$50.6m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
2
Funding Rounds
$33.8m
Money raised
A company developing immune therapies for cancer and related diseases
1
Funding Rounds
$24.0m
Money raised
Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.
6
Funding Rounds
$633.0m
Money raised
Caris Life Sciences is a medical diagnostics company developing molecular profiling combined with artificial intelligence founded in 1996 by David D. Halbert.
Enter your email and get access to 71,000 + technology companies you can partner with.